Using a translational data platform to create clinical-grade genome-informed risk assessments
JAMIA Open · 07.07.2026 · 9 (4)
DOI: 10.1093/jamiaopen/ooag118 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMIA Open, online erschienen am 13.07.2026. Verfasst von Jennifer L Morse und 27 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, United States. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHGRI NIH HHS, NHGRI.
Abstract (Originalsprache)
Objective
To describe the development and implementation of an automated platform for genomic risk prediction that integrates multiple data types. Materials and methods Using the REDCap infrastructure, we constructed the R4 (Recruitment, Results, and Risk Reduction) platform to intake data from clinical sites, partner laboratories, participant surveys, and electronic health record (EHR) data across 13 institutions.
Results
The R4 Portal successfully integrated data to generate genome-informed risk assessments (GIRAs) across 11 conditions for a 23 840 person cohort. Testing phases and quality control led to network-wide protocols ensuring consistency and accuracy.
Discussion
As the science of estimating disease risk evolves, standardized and high-throughput methods of collecting and manipulating complex data are required. Platforms should be open-source, modular, and reusable, ensuring flexibility, security, and integration across healthcare environments.
Conclusion
The electronic MEdical Records and GEnomics (eMERGE) network successfully generated and returned comprehensive risk profiles using logic and data specific to 11 conditions in a secure and semi-automated fashion employing a customized REDCap database.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, United States.
- Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, United States.
- Harvard Medical School, Boston, MA 02115, United States.
- Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, United States.
- Center for Genetic Medicine, Northwestern University, Chicago, IL 60611, United States.
ORCID-Profile: Cong Liu, Luke V Rasmussen
Förderung
- NHGRI NIH HHS
- NHGRI
Zitieren
APA
Morse, J. L., He, M., Bangash, H., Chung, W. K., Cortopassi, J., Forman, S., Gordon, A. S., Hamed, M., Harris, P. A., Karlson, E. W., Kenny, E. E., Kiryluk, K., Kullo, I. J., Lewis, A., Limdi, N., Liu, C., Marathe, P., McGuffin, K., Odgis, J., …, & Peterson, J. F. (2026). Using a translational data platform to create clinical-grade genome-informed risk assessments. JAMIA Open, 9(4). https://doi.org/10.1093/jamiaopen/ooag118
Vancouver
Morse JL, He M, Bangash H, Chung WK, Cortopassi J, Forman S, et al. Using a translational data platform to create clinical-grade genome-informed risk assessments. JAMIA Open. 2026;9(4). doi:10.1093/jamiaopen/ooag118
BibTeX
@article{Morse2026,
author = {Morse, Jennifer L and He, Megan and Bangash, Hana and Chung, Wendy K and Cortopassi, Joshua and Forman, Sophie and Gordon, Adam S and Hamed, Marwan and Harris, Paul A and Karlson, Elizabeth W and Kenny, Eimear E and Kiryluk, Krzysztof and Kullo, Iftikhar J and Lewis, Adam and Limdi, Nita and Liu, Cong and Marathe, Priya and McGuffin, Kyle and Odgis, Jacqueline and Perez, Emma and Petrzelka, Jacob and Prows, Cynthia A and Rasmussen, Luke V and Thomas, Ellis and Wiesner, Georgia L and Wilson, Travis and Linder, Jodell E and Peterson, Josh F},
title = {Using a translational data platform to create clinical-grade genome-informed risk assessments},
journal = {JAMIA Open},
year = {2026},
volume = {9},
number = {4},
doi = {10.1093/jamiaopen/ooag118}
}
EUVIMED